Invesaro

Stocks CLW Financial statements

Financial statements

Clearwater Paper Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Clearwater Paper Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,7351,7301,7241,7621,8691,7731,1951,1361,3841,555
Cost of revenue1,4941,5211,5371,5971,5741,5909839351,3081,440
Gross profit24120918816529418321320176.1116
Selling, general and administrative128121108113122113110119117101
Operating income11571.2-97.945.41581299.378.1-64.5-42.1
Interest expense39.549.844.435.511.711.83217.8
Interest income1.21.100.612.42.91.8
Other non-operating income-35.6-53.3-59.9-47.7-17.4-12.5-36.6-18
Pre-tax income80.740.9-134-7.9
Income tax31.1-56.410.3-2.321.1-7.729.216.9-27.1-7.1
Income from continuing operations52.748.7-74-53
Net income49.697.3-144-5.677.1-28.146108196-18.6
EBITDA206176416126911720317735.350.3
EPS, basic2.915.91-8.72-0.344.65-1.672.716.3911.70-1.15
EPS, diluted2.905.88-8.72-0.344.61-1.672.686.3011.70-1.15
Shares, basic (weighted)1716.516.516.516.616.81716.916.816.2
Shares, diluted (weighted)17.116.616.516.516.716.817.217.116.816.2

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents2315.722.52035.925.253.74279.630.7
Short-term investments0
Receivables14714214615916116718996.1189195
Inventory258266266281263278324161258282
Other current assets8.688.663.43.615.216.919.917.419.118.3
Total current assets446453444466475487586564545526
Property, plant and equipment9451,0511,2691,2581,1921,0821,0173611,0231,002
Lease right-of-use assets073.163.553.643.331.739.141.8
Goodwill24424435.135.135.135.148.60
Intangible assets40.532.524.1013.710.88.66.44.32.1
Other non-current assets7.7521.815.729.113412110047.657.960.4
Total assets1,6841,8021,7881,8781,8001,6901,7041,6721,6791,588
Accounts payable12816922816014315621389.1165131
Accrued liabilities49.94257.160.75829.341.932.838.233.6
Short-term debt15512217.91.71.60.900.60.6
Total current liabilities367419449280245254312286320216
Long-term debt570571693885716638565440282346
Lease liabilities065.654.342.735.924.228.331.7
Other non-current liabilities41.843.320.217.325.280.583.7
Total liabilities1,2141,2271,3621,4461,2791,1781,1321,003825763
Total debt570571693902718639566440273274
Paid-in capital3471.166.49.816.623.628.514.911.58.3
Retained earnings570618487482559531577685881862
Treasury stock-39500-3.3-14.8
Other comprehensive income-51.8-44-67.3-59.5-54.3-42.6-33.3-30.7-34.5-30.5
Shareholders' equity470575426432521512572669855825
Total equity470575426432521512572669855825
Total liabilities and equity1,6841,8021,7881,8781,8001,6901,7041,6721,6791,588

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income49.697.3-144-5.677.1-28.146108196-18.6
Depreciation and amortization91.110510211611110510398.699.892.4
Stock-based compensation12.43.63.34.110.59.112.79.95.63.8
Deferred income tax18.3-40.67.1-0.336.7-9.77.5-3.647.9-21.2
Change in receivables5.66.6-186.1-5.3-16.9-1.3-87.2-2.2
Change in inventory-14.8-8.1-21.218.1-20.2-46.3412.4-23.5
Change in payables31.325.2-28.5-121.949.2-21.398.9-75.3
Cash from operations17317916955.624796.415019161.412.3
Capital expenditures-155-200-296-140-39.6-38.4-33.5-73.7-117-88.8
Acquisitions-67.40000-7080
Cash from investing-223-199-224-140-39.6-25.1-33.5-73.7168-100
Debt issued0002962750022275382
Debt repaid000-103-449-81-80.9-326-931-18.6
Share buybacks-65.3-4.90000-5-17.9-10-17.2
Cash from financing67.113.863.382-193-82-88.6-129-19139.3
Net change in cash17.4-6.38.2-2.514.4-10.728.2-12.437.7-48.9
Free cash flow17.4-21-127-84.520758117117-55.2-76.5
Interest paid26.728.126.138.445363337.852.415.9
Income taxes paid17.72.7-10.63.1-7.9-7.74316.61953.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $20.34 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin5.1%Gross profit / revenue.
Operating margin-3.2%Operating income / revenue.
EBITDA margin2.9%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin-1.6%Net income / revenue.
FCF margin-3.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin0.7%Cash from operations / revenue.
Return on equity (ROE)-3.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-1.6%Net income / average total assets.
Return on invested capital (ROIC)-3.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue6.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.2%Capital expenditures / revenue.
D&A / revenue6.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y12.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y9.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-3.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y51.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-18.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-17.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y42.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-37.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-28.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-109.5%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-109.8%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-80.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-56.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-45.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-3.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-5.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-2.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.61xCurrent assets / current liabilities.
Quick ratio1.17x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.18x(Cash + short-term investments) / current liabilities.
Debt / equity0.34xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets17.4%Total debt / total assets.
Liabilities / assets48.2%Total liabilities / total assets.
Net debt$237.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA5.24xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage-2.54xOperating income / interest expense.
Working capital$321.7MCurrent assets - current liabilities.
Tangible book value$813.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.98xRevenue / average total assets.
Fixed asset turnover1.56xRevenue / average property, plant and equipment.
Inventory turnover5.41xCost of revenue / average inventory.
Days inventory67 days365 x average inventory / cost of revenue.
Receivables turnover7.77xRevenue / average receivables.
Days sales outstanding47 days365 x average receivables / revenue.
Days payables31 days365 x average accounts payable / cost of revenue.
Cash conversion cycle83 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow577.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.56Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$95.62Revenue / diluted weighted shares.
FCF per share-$3.35Free cash flow / diluted weighted shares.
Operating cash flow per share$0.70Cash from operations / diluted weighted shares.
Book value per share$50.61Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$50.61Tangible book value / shares outstanding.
Cash per share$2.27(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$328.0MShare price x shares outstanding.
Enterprise value$565.3MMarket cap + total debt - cash - short-term investments.
P/S0.21xMarket cap / revenue.
P/B0.40xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.40xMarket cap / tangible book value, when positive.
P/OCF29.0xMarket cap / cash from operations, when positive.
EV/Sales0.37xEnterprise value / revenue.
EV/EBITDA12.5xEnterprise value / EBITDA, when both are positive.
FCF yield-16.4%Free cash flow / market cap.
Earnings yield-7.7%Net income / market cap (the inverse of P/E).
Shareholder yield1.9%(Dividends paid + share buybacks) / market cap.
What was Clearwater Paper Corp's revenue in fiscal 2025?

Clearwater Paper Corp reported revenue of $1.56B for fiscal 2025, 12.4% higher than the year before.

Was Clearwater Paper Corp profitable in fiscal 2025?

No. It reported a net loss of $18.6M.

How much free cash flow did Clearwater Paper Corp generate in fiscal 2025?

Cash from operations of $12.3M minus capital expenditures of $88.8M left free cash flow of -$76.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Clearwater Paper Corp